Alamar Biosciences, Inc. (NASDAQ:ALMR – Get Free Report) Director Nicholas Naclerio acquired 235,294 shares of the stock in a transaction on Monday, April 20th. The shares were purchased at an average price of $17.00 per share, with a total value of $3,999,998.00. Following the completion of the transaction, the director owned 507,076 shares of the company’s stock, valued at approximately $8,620,292. This represents a 86.57% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link.
Alamar Biosciences Stock Performance
NASDAQ ALMR opened at $22.00 on Tuesday. Alamar Biosciences, Inc. has a fifty-two week low of $21.50 and a fifty-two week high of $24.50.
See Also
Receive News & Ratings for Alamar Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alamar Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
